Login to Your Account



Alemtuzumab In Phase III Testing Against Rebif In MS

By Staff Reports


Thursday, September 27, 2007
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription